BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10897167)

  • 1. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves.
    Kifune A; Kubota F; Shibata N; Akata T; Kikuchi S
    Epilepsia; 2000 Jul; 41(7):909-12. PubMed ID: 10897167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK; Gazioğlu S
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.
    Lokrantz CM; Eriksson B; Rosén I; Asztely F
    Acta Neurol Scand; 2004 Apr; 109(4):297-301. PubMed ID: 15016014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid-induced hyperammonemic encephalopathy: MR appearance.
    Baganz MD; Dross PE
    AJNR Am J Neuroradiol; 1994 Oct; 15(9):1779-81. PubMed ID: 7847228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperammonaemic encephalopathy due to valproic acid].
    Durán-Ferreras E; Jiménez-Vilches PL; Galá-Barranco JM; Fernández-Bolaños Porras R
    Rev Neurol; 2008 May 1-15; 46(9):537-9. PubMed ID: 18446695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
    Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate-induced hyperammonemic encephalopathy.
    Chou HF; Yang RC; Chen CY; Jong YJ
    Pediatr Neonatol; 2008 Oct; 49(5):201-4. PubMed ID: 19133574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-induced encephalopathy.
    Chen WT; Yen DJ; Yu HY; Liao KK
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Aug; 64(8):474-8. PubMed ID: 11720147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-related hyperammonemic encephalopathy with generalized suppression EEG: a case report.
    Liu X; Peng X
    Neurol Sci; 2023 Oct; 44(10):3669-3673. PubMed ID: 37243793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.
    Bøhmer T; Bøen A; Høymork SC
    Scand J Gastroenterol; 2010 Jun; 45(6):762-3. PubMed ID: 20163200
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
    Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
    Hamer HM; Knake S; Schomburg U; Rosenow F
    Neurology; 2000 Jan; 54(1):230-2. PubMed ID: 10636156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
    Vossler DG; Wilensky AJ; Cawthon DF; Kraemer DL; Ojemann LM; Caylor LM; Morgan JD
    Epilepsia; 2002 Feb; 43(2):154-9. PubMed ID: 11903461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-induced hyperammonemic encephalopathy.
    Murphy JV
    Epilepsia; 2003 Feb; 44(2):268; author reply 268. PubMed ID: 12558587
    [No Abstract]   [Full Text] [Related]  

  • 16. Valproate-induced hyperammonemic encephalopathy.
    Segura-Bruna N; Rodriguez-Campello A; Puente V; Roquer J
    Acta Neurol Scand; 2006 Jul; 114(1):1-7. PubMed ID: 16774619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burst Suppression Pattern on Electroencephalogram Secondary to Valproic Acid-Induced Hyperammonemic Encephalopathy.
    Cherian KA; Legatt AD
    Pediatr Neurol; 2017 Aug; 73():88-91. PubMed ID: 28545673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.
    Ziyeh S; Thiel T; Spreer J; Klisch J; Schumacher M
    Epilepsia; 2002 Sep; 43(9):1101-5. PubMed ID: 12199737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate increases the risk of valproic acid-induced encephalopathy.
    Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
    Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproicacid-induced hyperammonemic encephalopathy in the emergency department.
    Pliego Cosano R; Moreno Rosauro JM; Clavero Olmos M
    Emergencias; 2019 Oct; 31(5):364-365. PubMed ID: 31625314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.